SARS‐CoV‐2 variants and vulnerability at the global level
Numerous variants of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
pandemic have evolved. Viral variants may evolve with harmful susceptibility to the immunity …
pandemic have evolved. Viral variants may evolve with harmful susceptibility to the immunity …
Vaccine versus variants (3Vs): are the COVID-19 vaccines effective against the variants? A systematic review
Background: With the emergence and spread of new SARS-CoV-2 variants, concerns are
raised about the effectiveness of the existing vaccines to protect against these new variants …
raised about the effectiveness of the existing vaccines to protect against these new variants …
Effectiveness of COVID-19 vaccines against Delta (B. 1.617. 2) variant: a systematic review and meta-analysis of clinical studies
The high transmissibility, mortality, and morbidity rate of the SARS-CoV-2 Delta (B. 1.617. 2)
variant have raised concerns regarding vaccine effectiveness (VE). To address this issue, all …
variant have raised concerns regarding vaccine effectiveness (VE). To address this issue, all …
[HTML][HTML] Investigating linkages between spatiotemporal patterns of the COVID-19 Delta variant and public health interventions in Southeast Asia: prospective space …
Background: The COVID-19 Delta variant has presented an unprecedented challenge to
countries in Southeast Asia (SEA). Its transmission has shown spatial heterogeneity in SEA …
countries in Southeast Asia (SEA). Its transmission has shown spatial heterogeneity in SEA …
COVID-19 vaccine effectiveness against hospitalizations and ICU admissions in the Netherlands, April-August 2021
B de Gier, M Kooijman, J Kemmeren, N de Keizer… - MedRxiv, 2021 - medrxiv.org
The objective of this study was to estimate vaccine effectiveness (VE) against COVID-19
hospitalization and ICU admission, per period according to dominating SARS-CoV-2 variant …
hospitalization and ICU admission, per period according to dominating SARS-CoV-2 variant …
Homologous and heterologous boosting of the Chadox1-S1-S COVID-19 vaccine with the SCB-2019 vaccine candidate: a randomized, controlled, phase 2 study
SA Costa Clemens, EP Milan, E Sprinz… - Open Forum …, 2022 - academic.oup.com
Background Ongoing outbreaks of coronavirus disease 2019 (COVID-19) are driven by
waning immunity following primary immunizations and emergence of new severe acute …
waning immunity following primary immunizations and emergence of new severe acute …
Covid-19 vaccination programme effectiveness against SARS-CoV-2 related infections, hospital admissions and deaths in the Apulia region of Italy: a one-year …
T Homan, S Mazzilli, A Chieti, A Musa, A Roth… - Scientific Reports, 2022 - nature.com
Studies reporting vaccine effectiveness against COVID-19 outcomes concentrate mainly on
estimates of one single type of vaccine and variant, seldom considering waning effects. We …
estimates of one single type of vaccine and variant, seldom considering waning effects. We …
SARS-CoV-2 in silico binding affinity to human leukocyte antigen (HLA) Class II molecules predicts vaccine effectiveness across variants of concern (VOC)
SA Charonis, LM James, AP Georgopoulos - Scientific reports, 2022 - nature.com
There is widespread concern about the clinical effectiveness of current vaccines in
preventing Covid-19 caused by SARS-CoV-2 Variants of Concern (Williams in Lancet …
preventing Covid-19 caused by SARS-CoV-2 Variants of Concern (Williams in Lancet …
Virulence profiles of wild-type, P. 1 and Delta SARS-CoV-2 variants in K18-hACE2 transgenic mice
Y da Silva Santos, THM Gamon, MSP de Azevedo… - Viruses, 2023 - mdpi.com
Since December 2019, the world has been experiencing the COVID-19 pandemic caused
by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and we now face …
by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and we now face …
[PDF][PDF] Virulence profiles of wild-type
Y da Silva Santos, THM Gamon… - and Delta SARS-CoV …, 2023 - researchgate.net
Since December 2019, the world has been experiencing the COVID-19 pandemic caused
by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and we now face …
by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and we now face …